Oracea FDA Approval History
FDA Approved: Yes (First approved May 26, 2006)
Brand name: Oracea
Generic name: doxycycline
Dosage form: Capsules
Company: CollaGenex Pharmaceuticals, Inc.
Treatment for: Rosacea
Oracea is a once-a-day capsule formulation of doxycycline, consisting a combination of immediate and delayed release beads. Oracea is indicated for the treatment of inflammatory lesions (papules and pustules) of rosacea in adult patients.
Development Timeline for Oracea
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.